Dina Radenkovic, Gameto CEO
Exclusive: Fertility startup to begin Phase 3 study of stem cell therapy for IVF
Fertility startup Gameto has received permission from the FDA to see if its ovary-in-a-dish technology can make in vitro fertilization a less grueling process, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.